Verteporfin Photodynamic Therapy Combined with Intravitreal Ranibizumab for Polypoidal Choroidal Vasculopathy Controversy Concerning Long-Term Followup

Figure 5

Forty-five months after the onset of symptoms, the patient reported a loss of visual acuity (20/30) and he presented a neurosensory detachment of the fovea in the cirrus HD-OCT (a), and it was therefore decided to repeat the FA and the ICGA. FA showed hyperfluorescence associated with leakage (c), and no polyps were observed in the ICGA (d), and so in view of the loss of VA and evidence of fluid in the cirrus HD-OCT (a), treatment of 3 monthly intravitreal injections of ranibizumab was carried out.